Peptide-YY<sub>3-36</sub>/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.

Mol Metab · 2022 · PMC8717237 · PMID 34781035

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The ARC was not significantly activated, although a clear trend towards increased cFOS reactivity due to Fc-GLP-1 was present ( Figure 7 B).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.